---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-23-000034"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:31:34.667418+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Tarsus hosts investor webcast on TP-03 commercialization strategy; no new material financial data disclosed

## Summary
- Company hosted Virtual Investor Webcast on June 15, 2023, with corporate presentation on TP-03 for Demodex blepharitis.
- Presentation posted to investor section of website; no specific financial results or guidance provided.
- No material changes to business or financial condition disclosed.

## SEC filing metadata
- accession: 0001819790-23-000034
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/0001819790-23-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/tars-20230615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-23-000034
- JSON: https://secwatch.observer/filing/0001819790-23-000034.json
- Plain text: https://secwatch.observer/filing/0001819790-23-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.